Form 4 holding
President and CEO, Director
Eiger BioPharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 169,183
- Estimated value
- $50,366
- Report date
- 11 Mar 2022
- Price
- $0.2977
- Ownership
- Direct
David A. Cory
Insider Reports History
- Reporting-owner location
- Palo Alto, CA
- Latest reporting-owner signature
-
/s/ Sriram Ryali, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for David A. Cory
Form 4 holding
President and CEO, Director
Eiger BioPharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 281,000
- Estimated value
- Report date
- 11 Mar 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by David A. Cory
4
Eiger BioPharmaceuticals, Inc.
- Report period
- 11 Mar 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 11 Mar 2022, 20:06
- Role
- President and CEO, Director
- Next action
- Open filing details
4
Eiger BioPharmaceuticals, Inc.
- Report period
- 29 Jul 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 30 Jul 2021, 16:29
- Role
- President and CEO, Director
- Next action
- Open filing details